Clinical Trials Directory

Trials / Completed

CompletedNCT01731171

Probiotics to Prevent Relapse After Hospitalization for Mania

A Double-Blind Placebo-Controlled Trial of a Probiotic Supplement to Prevent Relapse and Improve the Clinical Course After Hospitalization for Mania

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
66 (actual)
Sponsor
Sheppard Pratt Health System · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if taking a probiotic supplement versus a placebo will lower rates of relapse and improve the clinical course among participants who have been hospitalized for mania. Relapse and clinical course are measured by time to re-hospitalizations, new mood episodes, and changes in mood-related symptoms.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotic SupplementProbiotic Supplement 1 tablet by mouth daily
DIETARY_SUPPLEMENTInert CompoundProbiotic identical placebo 1 tablet by mouth daily

Timeline

Start date
2012-11-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2012-11-21
Last updated
2019-01-07
Results posted
2019-01-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01731171. Inclusion in this directory is not an endorsement.

Probiotics to Prevent Relapse After Hospitalization for Mania (NCT01731171) · Clinical Trials Directory